
Revascularization Device, International Medical Device Company | Zylox …
Zylox Ton-bridge is a top player in peripheral and neurovascular interventional devices. Providing more than 40 quality revascularization products, our production line include ischemic & hemorrhagic stroke devices, vascular access products and so on.
企业简介 - 关于归创通桥 - 归创通桥 Zylox-Tonbridge
ZYLOX Penguin 静至®髂静脉支架系统、通桥麒麟™血流导向密网支架等多款重磅新品上市; 两款在研下肢动脉减容及CTO开通器械,获NMPA创新医疗器械认定; 归创通桥董事长赵中博士入选首批浙江省科技型企业家
ZYLOX Octoplus®腔静脉滤器
1)ZYLOX Octoplus®腔静脉滤器通过经股静脉或经颈静脉入路经皮置入,用于预防下腔静脉系统栓子脱落而引起的肺动脉栓塞(PE); 2)拥有90天超长回收周期及三重支撑结构,有效拦截血栓,减少继发血栓形成。
ZYLOX® SRK腔静脉滤器抓捕器
1)zylox®腔静脉滤器抓捕器由鞘管/扩张器套件和回收系统组成,适用于回收腔静脉滤器; 2)独特的 9f/11f 双回收鞘管系统,与扩张器组合过渡顺滑,搭配灵活,适用性广,可回收各种进口及国产滤器。
Zenflex™ Peripheral Stent System - ZYLOX-TONBRIDGE MEDICAL …
The ZENFLEX ® Peripheral Stent System is designed to deliver a self-expanding stent to the iliac artery, superficial femoral arteries and/or proximal popliteal arteries via a 6F delivery system. Unique Spiral Design. Excellent Vascular Compliance. MicroMesh Design. Gold/Tantalum Marker. Controlled Release System.
About - ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
We are one of the leading companies in the peripheral and neurovascular interventional medical device market in China. As a fully integrated medical device company, Zylox-Tonbridge medical has strong R&D and manufacturing capabilities, multiple specialized technology platforms, and proven commercialization capabilities.
Zylox Oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
Find patient medical information for Zylox oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
ZYLOX ® Phoenix Peripheral Detachable Fibrous Coil Embolization System is a domestically developed medical device for minimally invasive interventional treatment of peripheral arterial embolism.
ZYLOX SWAN RFI®静脉腔内射频闭合发生器
ZYLOX SWAN RFI®由 10.1 寸大液晶触摸屏显作为人机交互界面,提供、测量和显示射频输出功率和已用的射频递送时间,与导管中的传感器配合,在射频递送期间提供持续的测量温度显示。 Copyright © 2021 归创通桥医疗科技股份有限公司 All Rights Reserved. 浙ICP备2021008742号-2 互联网药品信息服务资格证书编号:(浙)-非经营性-2021-0090.
归创医疗ZYLOX Octoplus™腔静脉滤器获NMPA批准上市 - 雪球
Dec 14, 2022 · ZYLOX Octoplus™腔静脉滤器是归创医疗针对深静脉血栓及肺动脉栓塞疾病防治创新开发的全新一代医疗器械。 ZYLOX Octoplus™腔静脉滤器的创新结构设计,具有出色的腔静脉即刻贴壁性能和卓越的自主平衡能力,滤器释放精准、长期拦截血栓高效。
- Some results have been removed